MDM2 and cancer: Although GSK2830371 is a weak inhibitor of proliferation on different cancer cell lines, it dramatically potentiates the effect of MDM2 inhibitors, especially in cells where there is a WIP1/PPM1D overexpression or hyperactivation (Esfandiari et al., 2016).